213 related articles for article (PubMed ID: 32402715)
1. Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene.
Liu B; Chen L; Sun J; Zhang L; Chen M; Qian Y; Wang Y; Yan K; Hou L; Huang Y; Zhang D; Xu Y; Yu J; Zhang J; Dong M
Stem Cell Res; 2020 May; 45():101791. PubMed ID: 32402715
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human iPSC line (MPIi006-A) from a patient with Pelizaeus-Merzbacher disease.
Kim KP; Yoon J; Shin B; Röpke A; Han DW; Schöler HR
Stem Cell Res; 2020 Jul; 46():101839. PubMed ID: 32446239
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
[TBL] [Abstract][Full Text] [Related]
4. Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing.
Schreiber MK; Zafeiriou MP
Stem Cell Res; 2024 Feb; 74():103276. PubMed ID: 38104430
[TBL] [Abstract][Full Text] [Related]
5. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
[TBL] [Abstract][Full Text] [Related]
6. Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication.
Shimojima K; Inoue T; Imai Y; Arai Y; Komoike Y; Sugawara M; Fujita T; Ideguchi H; Yasumoto S; Kanno H; Hirose S; Yamamoto T
J Hum Genet; 2012 Sep; 57(9):580-6. PubMed ID: 22695888
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
[TBL] [Abstract][Full Text] [Related]
8. Proteolipid protein 1 gene mutation in nine patients with Pelizaeus-Merzbacher disease.
Wang JM; Wu Y; Wang HF; Deng YH; Yang YL; Qin J; Li XY; Wu XR; Jiang YW
Chin Med J (Engl); 2008 Sep; 121(17):1638-42. PubMed ID: 19024090
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the PLP1 gene residue p. Gly198 as the molecular basis of Pelizeaus-Merzbacher phenotype.
Hoffman-Zacharska D; Kmieć T; Poznański J; Jurek M; Bal J
Brain Dev; 2013 Oct; 35(9):877-80. PubMed ID: 23245814
[TBL] [Abstract][Full Text] [Related]
10. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
[TBL] [Abstract][Full Text] [Related]
11. A novel PLP1 mutation associated with optic nerve enlargement in two siblings with Pelizaeus-Merzbacher disease: A new MRI finding.
Pavlidou E; Ramachandran V; Govender V; Wilson C; Das R; Vlachou V; Pavlou E; Saggar A; Mankad K; Kinali M
Brain Dev; 2017 Mar; 39(3):271-274. PubMed ID: 27793435
[TBL] [Abstract][Full Text] [Related]
12. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
Laukka JJ; Kamholz J; Bessert D; Skoff RP
Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
[TBL] [Abstract][Full Text] [Related]
13. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional study of novel PLP1 mutations in Chinese patients with Pelizaeus-Merzbacher disease.
Xie H; Feng H; Ji J; Wu Y; Kou L; Li D; Ji H; Wu X; Niu Z; Wang J; Jiang Y
Brain Dev; 2015 Sep; 37(8):797-802. PubMed ID: 25491635
[TBL] [Abstract][Full Text] [Related]
15. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
[TBL] [Abstract][Full Text] [Related]
16. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease.
Shiihara T; Watanabe M; Moriyama K; Uematsu M; Sameshima K
Brain Dev; 2015 Apr; 37(4):455-8. PubMed ID: 25043250
[TBL] [Abstract][Full Text] [Related]
17. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
Elitt MS; Tesar PJ
Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived iPS cells for unveiling the molecular pathology of Pelizaeus-Merzbacher disease: a commentary on 'Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication'.
Inoue K
J Hum Genet; 2012 Sep; 57(9):553-4. PubMed ID: 22786577
[No Abstract] [Full Text] [Related]
19. Neurogenetics of Pelizaeus-Merzbacher disease.
Osório MJ; Goldman SA
Handb Clin Neurol; 2018; 148():701-722. PubMed ID: 29478609
[TBL] [Abstract][Full Text] [Related]
20. Pelizaeus-Merzbacher disease as a chromosomal disorder.
Yamamoto T; Shimojima K
Congenit Anom (Kyoto); 2013 Mar; 53(1):3-8. PubMed ID: 23480352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]